Phoenix, Arizona 85013


Purpose:

This study will compare genomic alterations between the parents and the patients with high-grade glioma.


Study summary:

Genomic changes leading to the formation of brain tumors are slowly being discovered. Despite advances in genomic technology, much analysis is hindered by the lack of control samples that could better delineate genomic alterations leading to disease. The ideal genomic control would be the genetic material of the parents of afflicted individuals. The researchers propose to then compare the genomic material from parents of siblings, both of whom have a diagnosis of a high-grade glioma. Additionally, the researchers will then compare the genomic alterations between the parents and the patients. This analysis will provide an unprecedented insight into genomic level changes that take place between parents and patients that resulted in the formation of a high-grade glioma.


Criteria:

Inclusion Criteria: - 18 years or older. - Family history of brain tumor in first degree relative Exclusion Criteria: - less than 18 years


NCT ID:

NCT02386241


Primary Contact:

Principal Investigator
Peter Nakaji, MD
Saint Joseph's Hospital and Medical Center/Barrow Neurological Institute

Norissa Honea, RN, PhD
Phone: 602-406-6267
Email: norissa.honea@dignityhealth.org


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85013
United States

Norissa Honea, PhD, RN
Phone: 602-406-6267
Email: Norissa.Honea@dignityhealth.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.